Page last updated: 2024-11-05

trimethoprim and Hypomelanosis

trimethoprim has been researched along with Hypomelanosis in 1 studies

Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.

Research Excerpts

ExcerptRelevanceReference
"Among the different modalities for treatment of cutaneous leishmaniasis, liquid nitrogen is considered an effective therapy with very mild side-effects."2.68A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis. ( Abuloham, O; al-Majali, O; Bhowmik, KR; Hebeheba, H; Muhsen, M; Routh, HB, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
al-Majali, O1
Routh, HB1
Abuloham, O1
Bhowmik, KR1
Muhsen, M1
Hebeheba, H1

Trials

1 trial available for trimethoprim and Hypomelanosis

ArticleYear
A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis.
    International journal of dermatology, 1997, Volume: 36, Issue:6

    Topics: Administration, Cutaneous; Adolescent; Adult; Anti-Infective Agents; Antimony; Cicatrix; Cryosurgery

1997